Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Cano Health Announces Financial Results for the Third Quarter 2022

      (PRNewsfoto/Cano Health, LLC)

      News provided by

      Cano Health, Inc.

      Nov 09, 2022, 16:05 ET

      Share this article

      Share this article


      MIAMI, Nov. 9, 2022 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company") (NYSE: CANO), a leading value-based primary care provider and population health company, today announced financial results for the third quarter ended September 30, 2022.

      Third Quarter Financial Results

      • Total membership of 294,596, including 168,346 Medicare capitated members, an increase of 40% year-over-year for both
      • Total revenue of $665.0 million, an increase of 33% year-over-year
      • Net loss of $(112.0) million, unfavorably impacted by a $65.7 million fair value adjustment of warrant liabilities
      • Adjusted EBITDA1 of $42.5 million, compared to $13.6 million in the third quarter of 2021, an increase of 211% year over year

      The Company continues to demonstrate financial and operational improvement year-over-year, with higher revenue, an improved medical cost ratio2, or MCR, and a higher Adjusted EBITDA margin. Total third-party medical costs per member per month, or PMPM, were better than expected in the third quarter, however, capitated revenue PMPM was approximately (5%) lower than the prior year and approximately (9%) lower than the second quarter of 2022, primarily due to a lower-than-expected capitated rates from new patients. This resulted in a higher medical cost ratio in the quarter than expected. The MCR was 78.2% in the third quarter, compared to 80.5% in the prior year, primarily driven by lower third-party medical costs PMPM, which more than offset the decline in capitated revenue PMPM.

      "Cano Health delivered improved profitability while achieving steady organic growth," said Dr. Marlow Hernandez, Chairman and Chief Executive Officer at Cano Health.  "While financial results were below our expectations due to lower revenue from new membership growth, existing membership performed in line with expectations.  As these new members integrate into our care platform, we expect they will perform similarly to existing members in future periods.  In response to our rapid growth and the higher cost of capital in the current economic environment, we are optimizing key areas of the business to leverage existing assets and prioritize cash flow.  We are confident Cano Health's operating model will continue to deliver better health outcomes for our patients and sustainable long-term value creation for our shareholders."

      ______________________

      (1) Adjusted EBITDA is a non-GAAP financial measure. A reconciliation of this non-GAAP financial measure to its most directly comparable GAAP financial measure is provided in the Reconciliation of Non-GAAP Adjusted EBITDA table included in this press release. An explanation of this measure and how it is calculated is also included under the heading "Non-GAAP Financial Measures."

      (2) Medical Claims Expense Ratio (MCR) is calculated as third-party medical expense divided by capitated revenue

      Guidance

      The Company is updating its guidance for full year 2022 provided on August 9, 2022.  The updated guidance for full year 2022 is as follows:

      • Membership in the range of 300,000 to 305,000, unchanged from the prior guidance range
      • Total revenue in the range of $2.70 billion to $2.75 billion, a decrease from the prior guidance range of $2.85 billion to $2.90 billion, primarily driven by lower-than-expected capitated revenue PMPM from new members
      • Total medical cost ratio (MCR) in the range of 79.5% to 80.5%, an increase from the prior range of 78.0% to 79.0%, driven by the aforementioned lower-than-expected capitated revenue PMPM from new members
        • The second half of 2022 is still expected to be lower than total MCR in the first half of 2022, primarily driven by normal seasonality in medical costs and cost recoveries
      • Adjusted EBITDA of approximately $150 million to $160 million, a decrease from the prior guidance of approximately $200 million
      • The Company added eight medical centers in the quarter, bringing total medical centers to 151, as of September 30, 2022, and 162 as of November 9, 2022; the Company expects to operate 170 by the end of 2022, a decrease from the prior guidance of 184 to 189, consistent with the focus on cash flow improvement

      As of November 4, 2022, the Company had approximately 245 million shares of Class A common stock and 250 million shares of Class B common stock issued and outstanding. Total share count for the purposes of calculating market capitalization was approximately 494 million.

      Conference Call Information

      Cano Health will host a conference call today at 5:00 PM ET to review the Company's business and financial results for the third quarter ended September 30, 2022.

      To access the live call and webcast, please dial (888) 660-6359 for U.S. participants, or +1 (929) 203-0867 for international participants, and reference the Cano Health Third Quarter 2022 Earnings Conference Call and Conference ID 8371699. The conference call will also be webcast live in the "Events & Presentations" section of the Investor page of the Cano Health website.

      A replay will be available in the "Events & Presentations" section of the Cano Health website for on-demand listening shortly after the completion of the call and will be available for 30 days.

      Forward-Looking Statements

      This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements relate to future events and involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and could materially affect actual results, performance or achievements. Such forward-looking statement include, without limitation, our anticipated results of operations, including our financial guidance for the 2022 fiscal year, our business strategies, our projected costs, prospects and plans, and other aspects of our operations or operating results. These forward-looking statements generally can be identified by phrases such as "will," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. It is uncertain whether any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do, what impact they will have on our results of operations and financial condition. Important risks and uncertainties that could cause our actual results and financial condition to differ materially from those indicated in forward-looking statements include, among others, changes in market or industry conditions, regulatory environment, competitive conditions, and receptivity to our services; changes in our strategy, future operations, prospects and plans; developments and uncertainties related to the Direct Contracting Entity ("DCE") DCE program; adverse effects on the Company's business as a result of the restatement of our previously issued financial statements; our ability to realize expected financial results, including with respect to patient membership, total revenue and earnings; our ability to predict and control our medical cost ratio; our ability to grow market share in existing markets or enter into new markets and continue our growth; our ability to integrate our acquisitions and achieve desired synergies; our ability to maintain our relationships with health plans and other key payors; the impact of COVID-19 on our business and results of operations; our future capital requirements and sources and uses of cash, including funds to satisfy our liquidity needs; and our ability to recruit and retain qualified team members and independent physicians. For a detailed discussion of the risks and uncertainties that could cause our actual results to differ materially from those expressed or implied by the forward-looking statements, please refer to our filings with the Securities and Exchange Commission (the "SEC"). All information provided in this press release is as of the date hereof, and we undertake no duty to update or revise this information unless required by law.

      Non-GAAP Financial Measures

      This press release contains certain non-GAAP financial measures as defined by the SEC rules. EBITDA and Adjusted EBITDA have not been prepared in accordance with United States generally accepted accounting principles ("GAAP"). EBITDA is defined as net income (loss) before interest, income taxes, depreciation and amortization. Adjusted EBITDA is defined as EBITDA, adjusted to add back the effect of certain expenses, such as stock-based compensation expense, de novo losses (consisting of costs associated with the ramp up of new medical centers and losses incurred for the twelve months after the opening of a new facility), acquisition transaction costs (consisting of transaction costs and corporate development payroll costs), restructuring and other charges, fair value adjustments in contingent consideration, loss on extinguishment of debt, and changes in fair value of warrant liabilities. We believe these non-GAAP financial measures provide an additional tool for investors to use in evaluating ongoing operating results and trends and in comparing our financial measures with other similar companies. We do not consider these non-GAAP measures in isolation or as an alternative to financial measures determined in accordance with GAAP.

      These non-GAAP financial measures are subject to inherent limitations as they reflect the exercise of judgments by management about which expense, income and other items are excluded or included in determining these non-GAAP financial measures. In addition, other companies may calculate non-GAAP financial measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of our non-GAAP financial measures as tools for comparison. A reconciliation of those measures to their most directly comparable GAAP measures is available under the heading "Reconciliation of Non-GAAP Measures." 

      The Company has not reconciled its expectations as to non-GAAP measures in future periods to their most directly comparable GAAP measure because certain costs and expenses are outside of its control or cannot be reasonably predicted.  Accordingly, reconciliation is not available without unreasonable effort, although it is important to note that these factors could be material to the Company's results computed in accordance with GAAP.

      About Cano Health 

      Cano Health (NYSE: CANO) is a high-touch, technology-powered healthcare company delivering personalized, value-based primary care to more than 290,000 members. With its headquarters in Miami, Florida, Cano Health is transforming healthcare by delivering primary care that measurably improves the health, wellness, and quality of life of its patients and the communities it serves. Founded in 2009, Cano Health has more than 4,500 employees, and operates primary care medical centers and supports affiliated providers in nine states and Puerto Rico. For more information,  visit canohealth.com or investors.canohealth.com.

      CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

      UNAUDITED

       
       

      Three Months Ended September 30,

       

      Nine Months Ended September 30,

      (in thousands, except share and per share data)

      2022

       

      2021

       

      2022

       

      2021

      Revenue:

                   

      Capitated revenue

      $             625,895

       

      $             473,763

       

      $          1,955,739

       

      $          1,064,604

      Fee-for-service and other revenue

      39,133

       

      25,168

       

      102,804

       

      52,510

      Total revenue

      665,028

       

      498,931

       

      2,058,543

       

      1,117,114

      Operating expenses:

                   

      Third-party medical costs

      489,565

       

      381,316

       

      1,566,661

       

      868,177

      Direct patient expense

      63,867

       

      50,368

       

      177,190

       

      120,212

      Selling, general and administrative expenses

      111,765

       

      76,618

       

      314,617

       

      158,786

      Depreciation and amortization expense

      25,343

       

      16,955

       

      64,215

       

      30,746

      Transaction costs and other

      5,033

       

      11,206

       

      19,616

       

      36,274

      Change in fair value of contingent
      consideration

      900

       

      (3,940)

       

      (9,525)

       

      (4,152)

      Total operating expenses

      696,473

       

      532,523

       

      2,132,774

       

      1,210,043

      Income (loss) from operations

      (31,445)

       

      (33,592)

       

      (74,231)

       

      (92,929)

      Other income and expense:

                   

      Interest expense

      (16,451)

       

      (16,023)

       

      (42,868)

       

      (36,363)

      Interest income

      4

       

      1

       

      7

       

      4

      Loss on extinguishment of debt

      —

       

      —

       

      (1,428)

       

      (13,225)

      Change in fair value of warrant liabilities

      (65,721)

       

      (14,650)

       

      (8,383)

       

      24,565

      Other income (expense)

      354

       

      (29)

       

      884

       

      (54)

      Total other income (expense)

      (81,814)

       

      (30,701)

       

      (51,788)

       

      (25,073)

      Net income (loss) before income tax expense

      (113,259)

       

      (64,293)

       

      (126,019)

       

      (118,002)

      Income tax expense (benefit)

      (1,248)

       

      547

       

      641

       

      (762)

      Net income (loss)

      $           (112,011)

       

      $              (64,840)

       

      $            (126,660)

       

      $           (117,240)

      Net income (loss) attributable to non-
      controlling interests

      (57,783)

       

      (41,602)

       

      (67,759)

       

      (98,559)

      Net income (loss) attributable to Class A
      common stockholders

      $             (54,228)

       

      $             (23,238)

       

      $             (58,901)

       

      $             (18,681)

                     

      Net income (loss) per share attributable to Class
      A common stockholders, basic

      $                  (0.23)

       

      $                  (0.14)

       

      $                  (0.28)

       

      $                  (0.11)

      Net income (loss) per share attributable to Class
      A common stockholders, diluted

      $                 (0.23)

       

      $                 (0.14)

       

      $                 (0.28)

       

      $                 (0.16)

      Weighted-average shares used in computation
      of earnings per share:

                   

      Basic

      232,314,170

       

      170,871,429

       

      211,408,974

       

      168,100,210

      Diluted

      232,314,170

       

      477,255,983

       

      211,408,974

       

      169,312,258

      CONDENSED CONSOLIDATED BALANCE SHEETS

      UNAUDITED

       
         

      As of,

      (in thousands)

       

      September 30,
      2022

       

      December 31,
      2021

      Assets

             

      Current assets:

             

      Cash, cash equivalents and restricted cash

       

      $           24,097

       

      $         163,170

      Accounts receivable, net of unpaid service provider costs

       

      202,037

       

      133,433

      Prepaid expenses and other current assets

       

      78,833

       

      20,632

      Total current assets

       

      304,967

       

      317,235

      Property and equipment, net

       

      125,513

       

      85,261

      Operating lease right of use assets

       

      171,442

       

      132,173

      Goodwill

       

      787,885

       

      769,667

      Payor relationships, net

       

      565,213

       

      576,648

      Other intangibles, net

       

      231,368

       

      248,973

      Other assets

       

      9,751

       

      13,582

      Total assets

       

      $      2,196,139

       

      $      2,143,539

      Liabilities and stockholders' equity

             

      Current liabilities:

             

      Current portion of notes payable

       

      $             6,444

       

      $             6,493

      Current portion of finance lease liabilities

       

      1,595

       

      1,295

      Current portion of contingent consideration

       

      5,700

       

      3,123

      Accounts payable and accrued expenses

       

      110,301

       

      80,829

      Current portions due to sellers

       

      2,038

       

      17,357

      Current portion operating lease liabilities

       

      24,946

       

      15,275

      Other current liabilities

       

      34,537

       

      36,664

      Total current liabilities

       

      185,561

       

      161,036

      Notes payable, net of current portion and debt issuance costs

       

      914,394

       

      915,266

      Long term portion of operating lease liabilities

       

      160,479

       

      122,935

      Warrants liabilities

       

      88,528

       

      80,144

      Long term portion of finance lease liabilities

       

      3,139

       

      2,181

      Contingent consideration

       

      28,000

       

      35,300

      Other liabilities

       

      33,004

       

      28,109

      Total liabilities

       

      1,413,105

       

      1,344,971

      Stockholders' Equity

             

      Shares of Class A common stock

       

      24

       

      18

      Shares of Class B common stock

       

      25

       

      30

      Additional paid-in capital

       

      544,106

       

      397,443

      Accumulated deficit

       

      (137,661)

       

      (78,760)

      Total Stockholders' Equity before non-controlling interests

       

      406,494

       

      318,731

      Non-controlling interests

       

      376,540

       

      479,837

      Total Stockholders' Equity

       

      783,034

       

      798,568

      Total Liabilities and Stockholders' Equity

       

      $      2,196,139

       

      $      2,143,539

      CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

      UNAUDITED

       
         

      Nine Months Ended
      September 30,

      (in thousands)

       

      2022

       

      2021

      Cash Flows from Operating Activities:

             

      Net loss

       

      $       (126,660)

       

      $       (117,240)

      Adjustments to reconcile net loss to net cash used in operating activities:

             

      Depreciation and amortization expense

       

      64,215

       

      30,746

      Change in fair value of contingent consideration

       

      (9,525)

       

      (4,152)

      Change in fair value of warrant liabilities

       

      8,383

       

      (24,565)

      Loss on extinguishment of debt

       

      1,428

       

      13,225

      Amortization of debt issuance costs

       

      2,743

       

      4,162

      Non-cash lease expense

       

      8,367

       

      —

      Class A shares issued for bonus award

       

      2,194

       

      —

      Stock-based compensation

       

      42,641

       

      13,131

      Changes in operating assets and liabilities:

             

      Accounts receivable, net

       

      (75,913)

       

      (25,494)

      Other assets

       

      10,885

       

      (9,874)

      Prepaid expenses and other current assets

       

      (47,492)

       

      (22,603)

      Interest accrued due to seller

       

      100

       

      1,208

      Accounts payable and accrued expenses

       

      30,955

       

      40,620

      Other liabilities

       

      3,521

       

      6,343

      Net cash provided by (used in) operating activities

       

      (84,158)

       

      (94,493)

      Cash Flows from Investing Activities:

             

      Purchase of property and equipment

       

      (39,061)

       

      (23,221)

      Acquisitions of subsidiaries including non-compete intangibles, net of cash acquired

       

      (4,995)

       

      (1,065,479)

      Payments to sellers

       

      (4,097)

       

      (24,148)

      Net cash provided by (used in) investing activities

       

      (48,153)

       

      (1,112,848)

      Cash Flows from Financing Activities:

             

      Business Combination and PIPE financing

       

      —

       

      935,362

      Payments of long-term debt

       

      (4,833)

       

      (656,294)

      Debt issuance costs

       

      (88)

       

      (16,489)

      Proceeds from long-term debt

       

      —

       

      1,120,000

      Proceeds from revolving line of credit

       

      25,000

       

      —

      Repayments of revolving line of credit

       

      (25,000)

       

      —

      Proceeds from insurance financing arrangements

       

      2,529

       

      1,702

      Payments of principal on insurance financing arrangements

       

      (2,070)

       

      (1,419)

      Principal payments under finance leases

       

      (1,037)

       

      (233)

      Repayment of equipment loans

       

      (385)

       

      (316)

      Employee stock purchase plan withholding tax payments

       

      (878)

       

      —

      Other

       

      —

       

      134

      Net cash provided by (used in) financing activities

       

      (6,762)

       

      1,382,447

               

      Net increase (decrease) in cash, cash equivalents and restricted cash

       

      (139,073)

       

      175,106

      Cash, cash equivalents and restricted cash at beginning of year

       

      163,170

       

      33,807

      Cash, cash equivalents and restricted cash at end of period

       

      $           24,097

       

      $        208,913

      Reconciliation of Non-GAAP

      Adjusted EBITDA

      UNAUDITED

       
       

      Three Months Ended
      September 30,

       

      Nine Months Ended

      September 30,

      (in thousands)

      2022

       

      2021

       

      2022

       

      2021

      Net loss

      $ (112,011)

       

      $   (64,840)

       

      $ (126,660)

       

      $ (117,240)

      Interest income

      (4)

       

      (1)

       

      (7)

       

      (4)

      Interest expense

      16,451

       

      16,023

       

      42,868

       

      36,363

      Income tax expense (benefit)

      (1,248)

       

      547

       

      641

       

      (762)

      Depreciation and amortization expense

      25,343

       

      16,955

       

      64,215

       

      30,746

      EBITDA

      $   (71,469)

       

      $   (31,316)

       

      $   (18,943)

       

      $   (50,897)

      Stock-based compensation

      11,041

       

      9,451

       

      42,641

       

      13,130

      De novo (1)

      24,282

       

      10,178

       

      59,567

       

      24,561

      Transaction costs (2)

      6,733

       

      12,503

       

      24,445

       

      39,297

      Restructuring and other (3)

      5,245

       

      2,123

       

      8,846

       

      5,513

      Change in fair value of contingent consideration

      900

       

      (3,940)

       

      (9,525)

       

      (4,152)

      Loss on extinguishment of debt

      —

       

      —

       

      1,428

       

      13,225

      Change in fair value of warrant liabilities

      65,721

       

      14,650

       

      8,383

       

      (24,565)

      Adjusted EBITDA

      $     42,453

       

      $     13,649

       

      $   116,842

       

      $    16,112

      ______________________

      (1) De novo losses include those costs associated with the ramp up of new medical centers and losses incurred after the opening of a new facility. These costs collectively are higher than comparable expenses incurred once such a facility has been opened and is generating revenue, and would not have been incurred unless a new facility was being opened.

       

      (2) Acquisition transaction costs included $1.7 million and $1.3 million for the three months ended June 30, 2022 and 2021, respectively, and $4.3 million and $3.0 million for the six months ended June 30, 2022 and 2021, respectively, of corporate development payroll costs. Corporate development payroll costs include those expenses directly related to the additional staff needed to support our acquisition activity.

       

      (3) Restructuring and other included $5.0 million  for the three and nine months ended September 30, 2022 related to a one-time professional services fee.

      Key Metrics

       
         

      Three Months Ended

       September 30,

         
         

      2022

       

      2021

       

      % Change

      Members:

                 

         Medicare Advantage

       

      128,731

       

      112,309

       

      14.6 %

         Medicare DCE

       

      39,615

       

      7,777

       

      409.4 %

      Total Medicare

       

      168,346

       

      120,086

       

      40.2 %

      Medicaid

       

      73,865

       

      63,871

       

      15.6 %

      ACA

       

      52,385

       

      26,706

       

      96.2 %

      Total members

       

      294,596

       

      210,663

       

      39.8 %

                   

      Member months:

                 

         Medicare Advantage

       

      383,645

       

      337,724

       

      13.6 %

         Medicare DCE

       

      119,936

       

      22,715

       

      428.0 %

      Total Medicare

       

      503,581

       

      360,439

       

      39.7 %

      Medicaid

       

      218,807

       

      187,212

       

      16.9 %

      ACA

       

      149,872

       

      81,437

       

      84.0 %

      Total member months

       

      872,260

       

      629,088

       

      38.7 %

                   

      Per Member Per Month ("PMPM"):

                 

         Medicare Advantage

       

      $             1,127

       

      $             1,151

       

      (2.1) %

         Medicare DCE

       

      $             1,215

       

      $             1,349

       

      (9.9) %

      Total Medicare

       

      $             1,148

       

      $             1,163

       

      (1.3) %

      Medicaid

       

      $                191

       

      $                271

       

      (29.5) %

      ACA

       

      $                  40

       

      $                  47

       

      (14.9) %

      Total PMPM

       

      $                718

       

      $                753

       

      (4.6) %

                   

      Medical centers

       

      151

       

      113

         

      Key Metrics

       
         

      Nine Months Ended

       September 30,

         
         

      2022

       

      2021

       

      % Change

      Members:

                 

         Medicare Advantage

       

      128,731

       

      112,309

       

      14.6 %

         Medicare DCE

       

      39,615

       

      7,777

       

      409.4 %

      Total Medicare

       

      168,346

       

      120,086

       

      40.2 %

      Medicaid

       

      73,865

       

      63,871

       

      15.6 %

      ACA

       

      52,385

       

      26,706

       

      96.2 %

      Total members

       

      294,596

       

      210,663

       

      39.8 %

                   

      Member months:

                 

         Medicare Advantage

       

      1,102,625

       

      820,881

       

      34.3 %

         Medicare DCE

       

      367,326

       

      46,639

       

      687.6 %

      Total Medicare

       

      1,469,951

       

      867,520

       

      69.4 %

      Medicaid

       

      627,634

       

      321,581

       

      95.2 %

      ACA

       

      411,138

       

      195,290

       

      110.5 %

      Total member months

       

      2,508,723

       

      1,384,391

       

      81.2 %

                   

      Per Member Per Month ("PMPM"):

                 

         Medicare Advantage

       

      $             1,189

       

      $             1,053

       

      12.9 %

         Medicare DCE

       

      $             1,320

       

      $             1,283

       

      2.9 %

      Total Medicare

       

      $             1,222

       

      $             1,066

       

      14.6 %

      Medicaid

       

      $                223

       

      $                414

       

      (46.1) %

      ACA

       

      $                  48

       

      $                  36

       

      33.3 %

      Total PMPM

       

      $                780

       

      $                769

       

      1.4 %

                   

      Medical centers

       

      151

       

      113

         

      SOURCE Cano Health, Inc.

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.